JNM
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Right arrow Help viewing high resolution images
Right arrow Return to article
Click on image to view larger version.



FIGURE 1. 18F-FDG PET and CT scans of patient with metastatic GIST in abdomen and liver before therapy (A and B); at 12 mo of imatinib mesylate therapy (C and D); and at 13 mo after withdrawal of imatinib mesylate for 1 mo (E and F). Maximum SUV of abdominal mass changed from 10.1 (A) to 1.3 (C) to 4.5 (E), and tumor size in longest dimension changed from 10.9 cm (B) to 11.3 cm (D) to 11.5 cm (F).





Right arrow Return to article


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
JOURNAL OF NUCLEAR MEDICINE TECHNOLOGY THE JOURNAL OF NUCLEAR MEDICINE